MX2022002586A - Isomeros de quelatos de manganeso. - Google Patents
Isomeros de quelatos de manganeso.Info
- Publication number
- MX2022002586A MX2022002586A MX2022002586A MX2022002586A MX2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A
- Authority
- MX
- Mexico
- Prior art keywords
- isomers
- manganese chelates
- chelates
- manganese
- mri
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a los isómeros de compuestos quelatos y su uso como agentes de contraste en procedimientos de resonancia magnética (MRI).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962895121P | 2019-09-03 | 2019-09-03 | |
PCT/EP2020/074645 WO2021043926A1 (en) | 2019-09-03 | 2020-09-03 | Manganese chelate isomers |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022002586A true MX2022002586A (es) | 2022-03-22 |
Family
ID=72356001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022002586A MX2022002586A (es) | 2019-09-03 | 2020-09-03 | Isomeros de quelatos de manganeso. |
Country Status (21)
Country | Link |
---|---|
US (1) | US20220315616A1 (es) |
EP (2) | EP4025259B1 (es) |
JP (2) | JP7644095B2 (es) |
KR (1) | KR20220058574A (es) |
CN (2) | CN119080772A (es) |
AU (1) | AU2020340541A1 (es) |
BR (1) | BR112022003242A2 (es) |
CA (1) | CA3152191A1 (es) |
DK (1) | DK4025259T3 (es) |
ES (1) | ES3010301T3 (es) |
FI (1) | FI4025259T3 (es) |
HR (1) | HRP20250045T1 (es) |
HU (1) | HUE069750T2 (es) |
LT (1) | LT4025259T (es) |
MX (1) | MX2022002586A (es) |
PL (1) | PL4025259T3 (es) |
PT (1) | PT4025259T (es) |
RS (1) | RS66436B1 (es) |
SI (1) | SI4025259T1 (es) |
SM (1) | SMT202500026T1 (es) |
WO (1) | WO2021043926A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201610738D0 (en) | 2016-06-20 | 2016-08-03 | Ge Healthcare As | Chelate compounds |
EP4464708A1 (en) | 2023-05-17 | 2024-11-20 | Bayer Aktiengesellschaft | New contrast agents for use in diagnostic imaging |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO331773B1 (no) | 2009-12-18 | 2012-03-26 | Ge Healthcare As | Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR) |
GB201610738D0 (en) | 2016-06-20 | 2016-08-03 | Ge Healthcare As | Chelate compounds |
KR20250079243A (ko) * | 2018-08-06 | 2025-06-04 | 브라코 이미징 에스.피.에이. | 가돌리늄 함유 pcta-기반 조영제 |
CN114105983B (zh) * | 2021-11-09 | 2023-08-11 | 国科温州研究院(温州生物材料与工程研究所) | 手性1,4,7,10-四氮杂-2,6-吡啶环蕃衍生物及其金属螯合物的制备和应用 |
-
2020
- 2020-09-03 ES ES20767545T patent/ES3010301T3/es active Active
- 2020-09-03 EP EP20767545.5A patent/EP4025259B1/en active Active
- 2020-09-03 JP JP2022514190A patent/JP7644095B2/ja active Active
- 2020-09-03 DK DK20767545.5T patent/DK4025259T3/da active
- 2020-09-03 FI FIEP20767545.5T patent/FI4025259T3/fi active
- 2020-09-03 MX MX2022002586A patent/MX2022002586A/es unknown
- 2020-09-03 CN CN202411197701.9A patent/CN119080772A/zh active Pending
- 2020-09-03 SM SM20250026T patent/SMT202500026T1/it unknown
- 2020-09-03 SI SI202030563T patent/SI4025259T1/sl unknown
- 2020-09-03 CN CN202080061544.2A patent/CN114423761B/zh active Active
- 2020-09-03 BR BR112022003242A patent/BR112022003242A2/pt unknown
- 2020-09-03 PL PL20767545.5T patent/PL4025259T3/pl unknown
- 2020-09-03 WO PCT/EP2020/074645 patent/WO2021043926A1/en active Application Filing
- 2020-09-03 CA CA3152191A patent/CA3152191A1/en active Pending
- 2020-09-03 RS RS20250080A patent/RS66436B1/sr unknown
- 2020-09-03 PT PT207675455T patent/PT4025259T/pt unknown
- 2020-09-03 HU HUE20767545A patent/HUE069750T2/hu unknown
- 2020-09-03 US US17/640,259 patent/US20220315616A1/en active Pending
- 2020-09-03 AU AU2020340541A patent/AU2020340541A1/en active Pending
- 2020-09-03 EP EP24209420.9A patent/EP4512815A3/en active Pending
- 2020-09-03 KR KR1020227010586A patent/KR20220058574A/ko active Pending
- 2020-09-03 LT LTEPPCT/EP2020/074645T patent/LT4025259T/lt unknown
- 2020-09-03 HR HRP20250045TT patent/HRP20250045T1/hr unknown
-
2025
- 2025-01-09 JP JP2025003174A patent/JP2025069163A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT4025259T (pt) | 2025-01-24 |
EP4512815A3 (en) | 2025-05-07 |
JP2022546554A (ja) | 2022-11-04 |
US20220315616A1 (en) | 2022-10-06 |
ES3010301T3 (en) | 2025-04-02 |
EP4512815A2 (en) | 2025-02-26 |
AU2020340541A1 (en) | 2022-04-21 |
DK4025259T3 (da) | 2025-01-20 |
HRP20250045T1 (hr) | 2025-03-14 |
CN114423761A (zh) | 2022-04-29 |
PL4025259T3 (pl) | 2025-03-03 |
BR112022003242A2 (pt) | 2022-05-17 |
RS66436B1 (sr) | 2025-02-28 |
JP2025069163A (ja) | 2025-04-30 |
HUE069750T2 (hu) | 2025-04-28 |
FI4025259T3 (fi) | 2025-01-13 |
WO2021043926A1 (en) | 2021-03-11 |
CN119080772A (zh) | 2024-12-06 |
JP7644095B2 (ja) | 2025-03-11 |
CN114423761B (zh) | 2024-09-24 |
SI4025259T1 (sl) | 2025-03-31 |
LT4025259T (lt) | 2025-02-10 |
SMT202500026T1 (it) | 2025-03-12 |
EP4025259A1 (en) | 2022-07-13 |
EP4025259B1 (en) | 2024-10-30 |
KR20220058574A (ko) | 2022-05-09 |
CA3152191A1 (en) | 2021-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2023012137A2 (es) | Nuevo agente de contraste para utilizar en imágenes por resonancia magnética | |
CO2017012490A2 (es) | Nuevos compuestos de quelato de gadolinio para usar en imágenes de resonancia magnética | |
CO2018006051A2 (es) | Compuestos inhibidores de la quinasa de unión a tank | |
MX2018007043A (es) | Agentes de contraste dimericos. | |
MX2020010847A (es) | Compuestos heterocíclicos deuterados y su uso como agentes formadores de imágenes. | |
CO7121325A2 (es) | Nuevos diazaespirocicloalcanos y azaespirocicloalcanos | |
MX2017002703A (es) | Sondas para la proyección de imagen de la proteína huntingtina. | |
MX2015011311A (es) | Nuevos derivados de octahidro-pirrolo[3,4-c]-pirrol y analogos del mismo como inhibidores de atotaxina. | |
MX385158B (es) | Derivados indol para uso en medicina. | |
BR112012027439A2 (pt) | derivados de n1-sulfonil-5-flúor-pirimidinona n3-substituídos | |
NZ749394A (en) | Chelate compounds | |
MX2022002586A (es) | Isomeros de quelatos de manganeso. | |
UY37500A (es) | Nuevos compuestos de quelato de gadolinio con alta relaxividad para usar en la obtencion de imagenes por resonancia magnetica | |
MX2020009022A (es) | Uso de alcoxipirazoles como inhibidores de la nitrificacion. | |
DOP2011000078A (es) | Derivados de piperazina que se unen a las placas amiloides para obtener imagenes de las mismas y su uso | |
UY29664A1 (es) | Complejos metalicos con contenido de prfluoroalquilo procedimientos para su preparacion, a´si como su uso | |
MX2019007595A (es) | Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri. | |
EP4064984A4 (en) | MAGNETIC RESONANCE IMAGING DEVICE | |
GB2599535B (en) | Novel magnetic resonance imaging contrast agents | |
DOP2009000080A (es) | Quelatos metálicos con un radical peg perfluorado, método para su preparación y uso | |
GT201400024A (es) | Derivados de n-(5-fluoro-2-((4-metilbencil)oxi)pirimidin-4-il) benzamida | |
RU2013145233A (ru) | МАГНИТОМЕТРИЧЕСКИЙ СПОСОБ ДИАГНОСТИКИ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ С ПОМОЩЬЮ НАНОЧАСТИЦ Yb-ПОРФИРИНОВОГО КОМПЛЕКСА |